1Scheig R. Primary Care; Clinics in Office.W. B. Saunders Company,1996.551
2Ravel.Clinical Laboratory Medicine.6th ed.Mosby-Year Book Inc,1995.309
3Giannini E, Botta F, Fasoli A, et al. Progressive liver functional impairment is associated with an increase in AST/ALT ratio. Dig Dis Sci,1999,44(6):1249
4Cavalletto L, Noventa F.Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-alpha. J Viral Hepat,1995,2: 91
5J. B. Whitfield. Gamma Glutamyl Transferase. Critical Reviews in Clinical Laboratory Sciences, 2001,38(4):263,355
6Fortunato G, Castaldo G, Oriani G, et al: six biochemical markers Clin Chem,2001,47(9):1696
2Garcia-Tsao G, Groszmann RJ, Fisher RL, et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepa- tology, 1985,5:419-424.
3D'Amico G, Pagliaro L, Bosch J. The treatment of portal hyper- tension. A meta-analytie review. Hepatology, 1995,22: 332-354.
4Grace ND. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroen- terology Practice Parameters Committee. Am J Gastroenterol, 1997,92:1081-1091.
5Murphy E, Prommer EE, Mihalyo M, et al. Octreotide. J Pain Symptom Manage, 2010,40 : 142-148.
